When 94% of providers report care delays tied to prior authorization requirements (AMA), specialty pharmacy leaders face a defining question: how do you scale without losing high-quality patient care and the human touch? For Shields Health Solutions, which integrates specialty…
Pharmacy
The FDA has cleared GSK’s respiratory syncytial virus vaccine for use in adults ages 18 to 49 who are at increased risk for severe disease. The vaccine, Arexvy, was originally approved in 2023 for use in adults 60 and older.…
A former pharmacy leader at Louisville, Ky.-based Baptist Health System, Jordan Propst, PharmD, has joined Greenville, S.C.-based Prisma Health. Dr. Propst announced the transition in a March 16 LinkedIn post, saying he is joining Prisma Health as pharmacy director of…
Clinicians are divided amid a growing demand for an unproven autism drug and wanting to preserve their patient-physician relationships, NPR reported March 16. Last fall, a federal press conference touted a new, unproven, treatment for autism: leucovorin. This derivative of…
Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on manufacturing in India. India supplies roughly 47% of all generic…
Medicaid spending on outpatient prescription drugs has climbed sharply in recent years even as utilization remained relatively flat and enrollment declined. A March 12 report from KFF outlines the key drivers of the increase and the early impact of new…
The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly negotiate prices for high-expenditure, single-source drugs covered by Medicare Part B…
Kroger is now offering Zepbound KwikPen, a multidose version of Eli Lilly’s GLP-1 weight loss drug, at participating retail pharmacy locations. The rollout marks the first time self-pay patients may be eligible to use Lilly’s savings program for Zepbound at…
A growing share of Americans worry about affording prescription drugs, with 59% saying they are at least somewhat concerned — the highest level recorded since 2018, according to a March 13 KFF poll. About 22% of respondents said they are…
Patients taking blood thinner Eliquis had a lower risk of clinically relevant bleeding than those taking Xarelto, a recent study found. Researchers enrolled 2,760 patients with venous thrombosis — blood clots in the veins of the legs or lungs —…